PMC:7326681 / 11872-11991 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T33","span":{"begin":10,"end":16},"obj":"Body_part"}],"attributes":[{"id":"A33","pred":"fma_id","subj":"T33","obj":"http://purl.org/sig/ont/fma/fma9601"}],"text":"ER+ early breast cancer patients should have neoadjuvant endocrine therapy before surgery during the COVID-19 pandemic."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T29","span":{"begin":10,"end":16},"obj":"Body_part"}],"attributes":[{"id":"A29","pred":"uberon_id","subj":"T29","obj":"http://purl.obolibrary.org/obo/UBERON_0000310"}],"text":"ER+ early breast cancer patients should have neoadjuvant endocrine therapy before surgery during the COVID-19 pandemic."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T95","span":{"begin":10,"end":23},"obj":"Disease"},{"id":"T96","span":{"begin":17,"end":23},"obj":"Disease"},{"id":"T97","span":{"begin":101,"end":109},"obj":"Disease"}],"attributes":[{"id":"A95","pred":"mondo_id","subj":"T95","obj":"http://purl.obolibrary.org/obo/MONDO_0007254"},{"id":"A96","pred":"mondo_id","subj":"T96","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"},{"id":"A97","pred":"mondo_id","subj":"T97","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"ER+ early breast cancer patients should have neoadjuvant endocrine therapy before surgery during the COVID-19 pandemic."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T80","span":{"begin":10,"end":16},"obj":"http://purl.obolibrary.org/obo/UBERON_0000310"}],"text":"ER+ early breast cancer patients should have neoadjuvant endocrine therapy before surgery during the COVID-19 pandemic."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T23","span":{"begin":57,"end":66},"obj":"Chemical"}],"attributes":[{"id":"A23","pred":"chebi_id","subj":"T23","obj":"http://purl.obolibrary.org/obo/CHEBI_24621"}],"text":"ER+ early breast cancer patients should have neoadjuvant endocrine therapy before surgery during the COVID-19 pandemic."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T46","span":{"begin":10,"end":23},"obj":"Phenotype"}],"attributes":[{"id":"A46","pred":"hp_id","subj":"T46","obj":"http://purl.obolibrary.org/obo/HP_0003002"}],"text":"ER+ early breast cancer patients should have neoadjuvant endocrine therapy before surgery during the COVID-19 pandemic."}

{"project":"LitCovid-sentences","denotations":[{"id":"T83","span":{"begin":0,"end":119},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"ER+ early breast cancer patients should have neoadjuvant endocrine therapy before surgery during the COVID-19 pandemic."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T111","span":{"begin":0,"end":2},"obj":"GO:0005783"},{"id":"T112","span":{"begin":10,"end":16},"obj":"UBERON:0000310"},{"id":"T113","span":{"begin":101,"end":109},"obj":"SP_7"},{"id":"T29876","span":{"begin":0,"end":2},"obj":"GO:0005783"},{"id":"T13856","span":{"begin":10,"end":16},"obj":"UBERON:0000310"},{"id":"T75822","span":{"begin":101,"end":109},"obj":"SP_7"}],"text":"ER+ early breast cancer patients should have neoadjuvant endocrine therapy before surgery during the COVID-19 pandemic."}

{"project":"LitCovid-PubTator","denotations":[{"id":"330","span":{"begin":0,"end":2},"obj":"Gene"},{"id":"332","span":{"begin":24,"end":32},"obj":"Species"},{"id":"340","span":{"begin":10,"end":23},"obj":"Disease"},{"id":"341","span":{"begin":101,"end":109},"obj":"Disease"}],"attributes":[{"id":"A330","pred":"tao:has_database_id","subj":"330","obj":"Gene:2069"},{"id":"A332","pred":"tao:has_database_id","subj":"332","obj":"Tax:9606"},{"id":"A340","pred":"tao:has_database_id","subj":"340","obj":"MESH:D001943"},{"id":"A341","pred":"tao:has_database_id","subj":"341","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ER+ early breast cancer patients should have neoadjuvant endocrine therapy before surgery during the COVID-19 pandemic."}